recently conducted an exploratory subgroups analysis of ECHELON-2 trial supporting the role of consolidation consolidative stem cell transplant (autologous or allogeneic) in CD30-positive PTCL who achieve a CR following treatment with A+CHP. The gene discussed is TNFRSF8; the disease is mature T-cell and NK-cell non-Hodgkin lymphoma.